TERF2 and neoplasm: As expected, intravenous injection of Paclitaxel (20 mg/kg once a week for two weeks) promoted a robust impairment of tumor growth in all the animals and, consistently with the in vitro results, over-expression of TRF2 enhanced significatively tumor sensitivity to the drug (Fig. 3a).